Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

COCLICAN

Financiado

Cerrado

COllaborative Consortium for the early detection of LIver CANcer

Hepatitis B (HBV) and C virus (HCV) are the most important etiologic agents of Hepatocellular carcinoma (HCC), which is the second leading cause of tumour related death in the world. The burden of HCC in developing countries repre... ver más

31/10/2022

IRD

451K€

Presupuesto del proyecto: 451K€

Líder del proyecto

INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-10-31

MSCA-RISE-2018: Research and Innovation Staff Excha...

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

IRD

174.80K€ | Lider

FMER

55.20K€ | Participante

MINISTRY OF HEALTH

UNIVERSITY OF TECHNOLOGY, KA...

36.80K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

HEPCIR Cell circuits as targets and biomarkers for liver disease an... 2M€ Cerrado

CONNASHION Vascular Control of NASH Progression 2M€ Cerrado

ESCALON European Latin American network for the assessment of biomar... 4M€ Cerrado

PROLIFICA Prevention of Liver Fibrosis and Cancer in Africa 5M€ Cerrado

IT-LIVER STRATEGY TO INHIBIT TGF Beta IN LIVER DISEASE 3M€ Cerrado

AURORAX Advancing cancer detection through metabolism based diagnost... 3M€ Cerrado

Duración del proyecto: 49 meses Fecha Inicio: 2018-09-20
Fecha Fin: 2022-10-31

Líder del proyecto

INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 451K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Hepatitis B (HBV) and C virus (HCV) are the most important etiologic agents of Hepatocellular carcinoma (HCC), which is the second leading cause of tumour related death in the world. The burden of HCC in developing countries represents a major challenge in global public health for the oncoming decades. Clinically, HCC patients have a very poor prognosis and high 5-year mortality rate except when detected early. As a result, HCC early detection is a critical parameter to anticipate the initiation of a tumour process, but affordable and discriminant diagnostic tools are lacking. A consortium of European and Third Countries institutions (Peru and Laos) gathered within the project COCLICAN proposes to tackle this issue through the analysis of metabolomics serum profiles of a large cohort of HBV-HBC infected patients to delineate a bunch of molecules predictive of the emergence of liver cancer. The performance of a low-cost and open-source echo-stethoscope connected to a smartphone will also be assessed, to allow early detection of tumorogenesis in health care underserved areas. This will be possible, thanks to the construction of a sustainable scientific and academic network of engineers, researchers and clinicians mobilised to exchange expertise, skills, technologies, biological material, deployed in three continents: Europe, South America and Asia. COCLICAN has been designed to improve research collaborations, to reinforce capacities, to enhance knowledge of partners and students involved in the project, but also to raise awareness of policy makers and to participate to the innovation potential improvement at the European and global levels. COCLICAN will therefore respond to the health needs of left behind populations, all around the world.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores